Trial intelligence / Profile preview

Intravenous colistin versus intravenous plus nebulized colistin for ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii

2007-006137-13Phase 3Active

Sponsor
Hospital Universitario Virgen del Rocío
Start
Feb 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of colistimethate sodium in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Hospital Universitario Virgen del Rocío. Started Feb 2008; status: active.

02

Drugs

colistimethate sodium
03

Conditions

ventilator-associated pneumonia (VAP)

Beyond the preview

Go deeper on 2007-006137-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-006137-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call